There has been an uptick in patients being treated for eating disorders who are abusing GLP-1 drugs like Ozempic, Mounjaro and Wegovy, according to research published Aug. 1 in the Journal of Clinical Psychopharmacology.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
